QQ客服 官方微博 反馈留言

	Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer
	Jiang Ren; Chuanjiang Yu; Shifei Wu; Feng Peng; Qianqian Jiang; Xuechao Zhang; Guoxing Zhong; Huashan Shi; Xiang Chen; Xiaolan Su
刊名	Current Cancer Drug Targets
	2014
卷号	Vol.14 No.2页码:167-180
关键词	Cationic liposome FUS1-hIL-12 eukaryotic coexpression Gene therapy HuPBL-NOD/SCID Lung cancer Molecular mechanism.
ISSN号	1568-0096
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1996246
专题	四川大学
作者单位	State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Keyuan 4th Road, NO. 1, Gaopeng Street, High Technological Development Zone, Chengdu, Sichuan, 610041, P. R. China.
推荐引用方式 GB/T 7714	Jiang Ren,Chuanjiang Yu,Shifei Wu,et al. Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer[J]. Current Cancer Drug Targets,2014,Vol.14 No.2:167-180.
APA	Jiang Ren.,Chuanjiang Yu.,Shifei Wu.,Feng Peng.,Qianqian Jiang.,...&Wen Zhu and Yuquan Wei.(2014).Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer.Current Cancer Drug Targets,Vol.14 No.2,167-180.
MLA	Jiang Ren,et al."Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer".Current Cancer Drug Targets Vol.14 No.2(2014):167-180.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。